ReviewWorld journal of surgical oncology2025
The current landscape and advances in functional-preserving gastric cancer surgery.
Review in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Preoperative total cholesterol and axillary lymph node burden in breast cancer: an exploratory analysis with a preliminary nomogram.Frontiers in surgery · 2026Article
- Differences in patient-reported symptoms following radical gastrectomy: a propensity score-matched cohort study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
With the gradual enhancement of public health literacy and advancements in gastroscopy technology, China has witnessed a steady increase in the detection rate of early-stage gastric cancer. Early-stage gastric cancer is characterized by favorable prognoses and prolonged survival times. In the treatment of early-stage gastric cancer, maintaining postoperative quality of life while ensuring curability without excessive intervention is crucial and remains a focal point in current therapeutic strategies. This can be addressed through minimally invasive, function-preserving gastrectomy. Laparoscopic proximal gastrectomy, pylorus-preserving gastrectomy, segmental gastrectomy, local gastrectomy, and laparoscopic-endoscopic combined surgery are all examples of function-preserving procedures. In proximal gastrectomy, reconstruction typically involves anti-reflux techniques such as esophagogastrostomy, double-tract reconstruction, and jejunal interposition. Currently, the Kamikawa anastomosis, as a method to prevent reflux esophagitis, has become the preferred reconstruction technique in Japan. However, a standardized reconstruction method following proximal gastrectomy has yet to be established. Additionally, sentinel lymph node navigation surgery is essential for maintaining the curability of early-stage gastric cancer through minimally invasive, function-preserving gastrectomy. It aids in intraoperative lymph node localization, assesses lymph node metastasis, and determines the extent of lymphadenectomy, thereby enhancing postoperative quality of life for early-stage gastric cancer patients. Internationally, sentinel lymph node navigation surgery has been established as a treatment option for specific early-stage gastric cancer patients, with its application expected to expand in the future. This article reviews the current research status of function-preserving gastrectomy for gastric cancer both domestically and internationally. It details various function-preserving surgical methods, analyzes and summarizes their clinical efficacy, aiming to provide valuable references for surgeons to better perform such surgeries. This, in turn, will promote the standardized application and further development of function-preserving gastrectomy for gastric cancer in clinical practice. Keywords: Gastric Cancer; Functional-Preserving Surgery; Gastrectomy; Digestive Tract Reconstruction;Surgical treatmentIntroduction According to the 2022 Global Cancer Statistics released by the International Agency for Research on Cancer of the World Health Organization, GC ranks 5th in incidence and 4th in mortality globally [1]. Traditional surgical complications, such as postoperative malnutrition, anemia, and inadequate anti-reflux, significantly impact patients' quality of life. Therefore, reconstructing the anti-reflux barrier and preserving the residual stomach's function during surgical treatment are critical concerns. In recent years, functional preservation surgeries for GC have gained traction, aiming to retain part of the stomach's anatomical and physiological functions while ensuring radical tumor resection, thereby enhancing postoperative quality of life [2]. In functional-preserving gastrectomy, precise assessment of lymph node metastasis status is crucial for determining surgical approaches, predicting prognosis, and guiding subsequent treatments, requiring a balance between tumor radicality and functional preservation. Lymph node metastasis is a pivotal biological behavior in malignant tumor progression, involving tumor cells detaching from the primary site, colonizing lymph nodes via the lymphatic circulation, and proliferating, resulting from interactions between tumor cells and the host microenvironment. The pathophysiological mechanisms involve complex multi-step, multi-factor regulation of tumor cell invasion, migration, and colonization. Diagnosis of lymph node metastasis necessitates clinical, imaging, and pathological methods, with pathological diagnosis serving as the "gold standard" ,including intraoperative frozen section biopsy of suspicious lymph nodes, postoperative paraffin-embedded cases, and sentinel lymph node biopsy. With advancements in molecular diagnostic technologies, future identification of micrometastases and potential metastatic risks will become more precise, providing stronger support for assessing lymph node metastasis. Currently, widely used functional-preserving surgeries include proximal gastrectomy(PG), pylorus-preserving gastrectomy(PPG), segmental gastrectomy(SG), local gastrectomy(LG), and laparoscopic-endoscopic combined surgeries(LECS).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.